Sign In
Buy NUMIF
$0.0308
-0.0014 (-4.35%)
At Close: Jul 31, 2026
Numinus Wellness research facility licensed by Health Canada to supply psilocybin mushrooms
09:31am, Thursday, 27'th Jan 2022
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada's list of federally licensed psilocybin producers. This list i
Numinus Wellness Reveals 244.5% YoY Improvement In Q1 Revenue & Wider Loss
10:16am, Friday, 21'st Jan 2022
Numinus Wellness Inc (TSX:NUMI) (OTC:NUMIF) reported its fiscal first-quarter results Thursday for the three months ended Nov. 30, 2021. Based in Vancouver, the company said that it ended the quarter
Numinus Wellness sees big jump in revenue in 1Q as Health Canada expands Special Access Program for psychedelic treatment
04:54pm, Thursday, 20'th Jan 2022
Numinus Wellness Inc reported a big jump in its 1Q 2022 revenue just as Health Canada has expanded its Special Access Program to enable easier access to psychedelic-assisted therapy. The mental health
Numinus Wellness reports key milestones in MAPS-sponsored MDMA-assisted therapy for PTSD clinical trial
10:00am, Wednesday, 19'th Jan 2022
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) said it has completed key steps to prepare to enroll participants at its clinics participating in a multi-site open-label extension study of MDMA-assiste
Numinus Wellness submits Health Canada application for Phase 1 study of proprietary psilocybin formulation NBIO-01
09:13am, Friday, 14'th Jan 2022
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) said it has formally submitted the clinical trial application (CTA) to Health Canada for its Phase 1 study (HOPE) of its naturally derived psilocybe extr
[Watch] How Psychedelics Will Change Society, MAPS Partnership With Numinus Wellness CEO
09:02am, Thursday, 23'rd Dec 2021
This article by Sarah Abelsohn was originally published on Psychedelic Spotlight, and appears here with permission.
Numinus Wellness hails Health Canada on SAP amendments to expand potential access to psychedelic medicines
08:25am, Thursday, 23'rd Dec 2021
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF), a leader in psychedelics-focused mental healthcare, applauded Health Canada's leadership in amending the Special Access Programme (SAP) to allow physicia
Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness
08:45am, Thursday, 16'th Dec 2021
Trifecta of psychedelics healing and wellness solutions Numinus Bioscience is a Health Canada-licensed lab Numinus R&D is developing psychedelic-assisted therapeutic protocols Numinus Health supports
